You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases
|
|---|---|
| Published in |
Frontiers in Neurology, October 2015
|
| DOI | 10.3389/fneur.2015.00216 |
| Pubmed ID | |
| Authors |
Babette L. R. Reijs, Charlotte E. Teunissen, Nikolai Goncharenko, Fay Betsou, Kaj Blennow, Inês Baldeiras, Frederic Brosseron, Enrica Cavedo, Tormod Fladby, Lutz Froelich, Tomasz Gabryelewicz, Hakan Gurvit, Elisabeth Kapaki, Peter Koson, Luka Kulic, Sylvain Lehmann, Piotr Lewczuk, Alberto Lleó, Walter Maetzler, Alexandre de Mendonça, Anne-Marie Miller, José L. Molinuevo, Brit Mollenhauer, Lucilla Parnetti, Uros Rot, Anja Schneider, Anja Hviid Simonsen, Fabrizio Tagliavini, Magda Tsolaki, Marcel M. Verbeek, Frans R. J. Verhey, Marzena Zboch, Bengt Winblad, Philip Scheltens, Henrik Zetterberg, Pieter Jelle Visser |
| Abstract |
Biobanks are important resources for biomarker discovery and assay development. Biomarkers for Alzheimer's and Parkinson's disease (BIOMARKAPD) is a European multicenter study, funded by the EU Joint Programme-Neurodegenerative Disease Research, which aims to improve the clinical use of body fluid markers for the diagnosis and prognosis of Alzheimer's disease (AD) and Parkinson's disease (PD). The objective was to standardize the assessment of existing assays and to validate novel fluid biomarkers for AD and PD. To support the validation of novel biomarkers and assays, a central and a virtual biobank for body fluids and associated data from subjects with neurodegenerative diseases have been established. In the central biobank, cerebrospinal fluid (CSF) and blood samples were collected according to the BIOMARKAPD standardized pre-analytical procedures and stored at Integrated BioBank of Luxembourg. The virtual biobank provides an overview of available CSF, plasma, serum, and DNA samples at each site. Currently, at the central biobank of BIOMARKAPD samples are available from over 400 subjects with normal cognition, mild cognitive impairment (MCI), AD, frontotemporal dementia (FTD), vascular dementia, multiple system atrophy, progressive supranuclear palsy, PD, PD with dementia, and dementia with Lewy bodies. The virtual biobank contains information on over 8,600 subjects with varying diagnoses from 21 local biobanks. A website has been launched to enable sample requests from the central biobank and virtual biobank. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 10% |
| Unknown | 9 | 90% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 90% |
| Scientists | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Netherlands | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 107 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 19 | 17% |
| Researcher | 17 | 15% |
| Student > Master | 9 | 8% |
| Student > Doctoral Student | 7 | 6% |
| Student > Bachelor | 6 | 5% |
| Other | 18 | 16% |
| Unknown | 34 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 18 | 16% |
| Neuroscience | 14 | 13% |
| Biochemistry, Genetics and Molecular Biology | 8 | 7% |
| Agricultural and Biological Sciences | 8 | 7% |
| Psychology | 5 | 5% |
| Other | 14 | 13% |
| Unknown | 43 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2015.
All research outputs
#2,166,515
of 23,323,574 outputs
Outputs from Frontiers in Neurology
#1,058
of 12,239 outputs
Outputs of similar age
#31,856
of 280,381 outputs
Outputs of similar age from Frontiers in Neurology
#15
of 64 outputs
Altmetric has tracked 23,323,574 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,239 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 280,381 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.